ELAPRASE 6 mg/3mL
idursulfase · SOLUTION, CONCENTRATE · Takeda Pharmaceuticals America, Inc.
ELAPRASE is a solution, concentrate containing idursulfase at 6 mg/3mL, taken intravenous. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- ELAPRASE
- Generic Name
- idursulfase
- NDC Code (Product)
54092-700- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Strength
- 6 mg/3mL
- Dosage Form
- SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125151
- Drug Class
- Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC]
- Marketing Start
- 07/24/2006
Recall History
No Recall HistoryFrequently Asked Questions
What is ELAPRASE used for?
ELAPRASE contains idursulfase. It is a solution, concentrate taken intravenous. Consult your doctor for specific uses.
Is ELAPRASE a controlled substance?
ELAPRASE is not classified as a controlled substance by the DEA.
What is the generic name for ELAPRASE?
The generic name for ELAPRASE is idursulfase. There are no other listed brand versions of idursulfase.
What is the NDC code for ELAPRASE 6 mg/3mL?
The NDC (National Drug Code) for ELAPRASE 6 mg/3mL is 54092-700, listed by Takeda Pharmaceuticals America, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)